Clinical trial Recruiting at 1 site Observational Ages 45 to 100

Evaluating plaque characteristics to predict recurrent strokes in MCA stroke patients

Official title: Plaque Characteristics From Vessel Wall Magnetic Resonance Imaging Predict Recurrent Stroke in Ischemic Stroke Patients Due to Middle Cerebral Artery Stenosis

Run by University Medical Center Ho Chi Minh City (UMC) · NCT06404242 · Data updated 2026-11-12

This study is testing if certain features of plaque in the arteries can help predict if people over 45 who had a stroke will have another one.

Quick facts

Study typeObservational
Ages45 Years to 100 Years
SexAll
Enrollment75 (estimated)
SponsorUniversity Medical Center Ho Chi Minh City (UMC)
Academic / other
Locations1 site (Ho Chi Minh City, Ho Chi Minh City)
StatusRecruiting
StartedMay 27, 2024
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedAugust 6, 2026
Trial IDNCT06404242 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients over 45 years old who have had a first-time ischemic stroke due to MCA atherosclerosis with more than 50% stenosis.

Probably not a fit

Patients with carotid artery stenosis, strokes in territories other than MCA, or those with alternative causes for their stenosis will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the correlation between plaque characteristics observed through high-resolution MRI (HR-MRI) and the occurrence of recurrent strokes in patients who have experienced their first ischemic stroke due to middle cerebral artery (MCA) atherosclerosis. The study focuses on patients over 45 years old who have significant stenosis and have undergone a comprehensive stroke workup. By analyzing the complex pathology of atherosclerosis, the researchers hope to identify specific plaque features that could indicate a higher risk of recurrent strokes, thereby improving treatment strategies based on individual etiology.

Why it matters

Potential benefit: If successful, this study could lead to better prediction and prevention of recurrent strokes in patients with atherosclerosis.

How similar studies have gone: Previous studies have shown promising results in using HR-MRI to predict recurrent strokes, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients who had a first-time ischemic stroke due to MCA atherosclerosis stenosis more than 50% and admitted to our hospital within 7 days after onset.
* Patients are more than 45 years old.
* Patients had HR-MRI and have done the full stroke workup (including carotid duplex scanning, fasting lipid profile, Holter ECG 24 hours, cardiac ultrasound,...)

Exclusion Criteria:

* Patients also have stenosis of the carotid artery (more than 50%) or occulsion on the same side of ischemic stroke
* Patients also have an ischemic stroke in territories other than MCA territory.
* Patients had any characteristics that suggested other causes for their stenosis, including moyamoya, dissection, and inflammation on their MRI and HR-MRI.
* Patients with evidence suggestive of cardioembolism (Atrial fibrillation, decreased EF \<50%, recent heart attack in 3 weeks, rheumatic valvular heart disease, dilated cardiopathy, sick sinus syndrome, infective endocarditis).
* Any signs suggestive other causes (non atherosclerosis etiology), including autoimmune disease or increased coagulation state.
* Patients with severe concomitant disease could affect the 6-month follow-up of the patients.

Where it's running

  • University Medical Center Ho Chi Minh City
    Ho Chi Minh City, Ho Chi Minh City, Vietnam
    Recruiting

Study contacts

  • Principal investigator: Khoa Dao, MD — University Medical Center Ho Chi Minh City
  • Study coordinator: Khoa Dao, MD
  • Email: khoa.dd@umc.edu.vn
  • Phone: +84986883254

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.